Clinical Trial Update: Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II trial comparing PAP Plus GM-CSF versus GM-CSF alone in non-metastatic prostate cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• PAP (PAP)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-25